Published in Annu Rev Immunol on January 01, 1983
Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J Exp Med (1992) 3.77
Antigen localization and migration in immunity and tolerance. N Engl J Med (1998) 3.71
Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J Exp Med (1992) 3.52
Interferon gamma plays a critical role in induced cell death of effector T cell: a possible third mechanism of self-tolerance. J Exp Med (1990) 3.45
T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci U S A (1992) 2.98
Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J Exp Med (1993) 2.62
Heat-stable antigen is a costimulatory molecule for CD4 T cell growth. J Exp Med (1992) 2.42
Short-term immunosuppression promotes engraftment of embryonic and induced pluripotent stem cells. Cell Stem Cell (2011) 2.35
Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg (1998) 2.31
Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc Natl Acad Sci U S A (1995) 2.06
Transplantation tolerance from a historical perspective. Nat Rev Immunol (2001) 2.04
Dendritic cell entrapment within the pregnant uterus inhibits immune surveillance of the maternal/fetal interface in mice. J Clin Invest (2009) 1.74
Transplantation tolerance, microchimerism, and the two-way paradigm. Theor Med Bioeth (1998) 1.67
Stimulation of mature unprimed CD8+ T cells by semiprofessional antigen-presenting cells in vivo. J Exp Med (1992) 1.61
A two-step, two-signal model for the primary activation of precursor helper T cells. Proc Natl Acad Sci U S A (1999) 1.58
Strong T cell tolerance in parent----F1 bone marrow chimeras prepared with supralethal irradiation. Evidence for clonal deletion and anergy. J Exp Med (1990) 1.54
Distinct costimulatory molecules are required for the induction of effector and memory cytotoxic T lymphocytes. J Exp Med (1997) 1.47
Role of antigen-presenting cells in mediating tolerance and autoimmunity. J Exp Med (2000) 1.46
Expression in transgenic mice of class I histocompatibility antigens controlled by the metallothionein promoter. Proc Natl Acad Sci U S A (1989) 1.44
Cells that present both specific ligand and costimulatory activity are the most efficient inducers of clonal expansion of normal CD4 T cells. Proc Natl Acad Sci U S A (1992) 1.44
T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: an important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells. J Exp Med (1994) 1.43
The activation and inactivation of mature CD4 T cells: a case for peripheral self-nonself discrimination. Scand J Immunol (2014) 1.41
Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor alpha leads to autoimmunity in transgenic mice. Proc Natl Acad Sci U S A (1994) 1.38
Cell surface signaling molecules in the control of immune responses: a tide model. Immunity (2011) 1.32
Pancreas transplantation. An immunohistologic and histopathologic examination of 100 grafts. Am J Pathol (1987) 1.21
A reexamination of the role of LYT-2-positive T cells in murine skin graft rejection. J Exp Med (1984) 1.17
CTLA-4-B7 interaction is sufficient to costimulate T cell clonal expansion. J Exp Med (1997) 1.13
B7H costimulates clonal expansion of, and cognate destruction of tumor cells by, CD8(+) T lymphocytes in vivo. J Exp Med (2001) 1.13
Identification of a costimulatory molecule rapidly induced by CD40L as CD44H. J Exp Med (1996) 1.10
Antigen presentation events in autoimmune diabetes. Curr Opin Immunol (2011) 1.08
Chimerism and tolerance in transplantation. Proc Natl Acad Sci U S A (2004) 1.07
T-cell responsiveness to an oncogenic peripheral protein and spontaneous autoimmunity in transgenic mice. Proc Natl Acad Sci U S A (1992) 1.05
The role of CD4+ and CD8+ T cells in the destruction of islet grafts by spontaneously diabetic mice. Proc Natl Acad Sci U S A (1991) 1.05
Islet product characteristics and factors related to successful human islet transplantation from the Collaborative Islet Transplant Registry (CITR) 1999-2010. Am J Transplant (2014) 1.04
PD-1, PD-L1 (B7-H1) and Tumor-Site Immune Modulation Therapy: The Historical Perspective. J Hematol Oncol (2017) 0.99
T cell contact with Ia antigens on nonhemopoietic cells in vivo can lead to immunity rather than tolerance. J Exp Med (1991) 0.98
Acquired immunologic tolerance: with particular reference to transplantation. Immunol Res (2007) 0.97
Pattern of graft- and host-specific MHC class II expression in long-term murine cardiac allografts: origin of inflammatory and vascular wall cells. Am J Pathol (1998) 0.96
Evidence that the effector mechanism of skin allograft rejection is antigen-specific. Proc Natl Acad Sci U S A (1988) 0.96
The unfinished legacy of liver transplantation: emphasis on immunology. Hepatology (2006) 0.93
The relative contribution of the CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells. J Exp Med (1996) 0.93
Naturally occurring altered peptide ligands control Salmonella-specific CD4+ T cell proliferation, IFN-gamma production, and protective potency. J Immunol (2009) 0.92
The pathophysiology of experimental insulin-deficient diabetes in the monkey. Implications for pancreatic transplantation. Ann Surg (1985) 0.92
StrataGraft skin substitute is well-tolerated and is not acutely immunogenic in patients with traumatic wounds: results from a prospective, randomized, controlled dose escalation trial. Ann Surg (2011) 0.91
The central role of antigen presentation in islets of Langerhans in autoimmune diabetes. Curr Opin Immunol (2013) 0.90
Transplantation tolerance: from theory to clinic. Immunol Rev (2014) 0.88
Efficient gene disruption in cultured primary human endothelial cells by CRISPR/Cas9. Circ Res (2015) 0.88
Hepatitis B virus infection of transplanted human hepatocytes causes a biochemical and histological hepatitis in immunocopetentent rats. World J Gastroenterol (2003) 0.84
Cellular transplants. Transplant Proc (1991) 0.82
Costimulation couture: a designer approach to regulating autoimmunity. J Clin Invest (2006) 0.82
Transforming growth factor beta decreases the immunogenicity of rat islet xenografts (rat to mouse) and prevents rejection in association with treatment of the recipient with a monoclonal antibody to interferon gamma. Proc Natl Acad Sci U S A (1990) 0.82
Protection of mice against tumor growth by immunization with an oncogene-encoded growth factor. Proc Natl Acad Sci U S A (1990) 0.82
Selective transplantation. An emerging concept. Ann Surg (1985) 0.82
Pancreatic islet transplantation. Induction of graft acceptance by ultraviolet irradiation of donor tissue. Ann Surg (1984) 0.81
A proteomic view at T cell costimulation. PLoS One (2012) 0.80
Major histocompatibility complex protein expression on pancreas and pancreatic islet endocrine cell subsets. Am J Pathol (1989) 0.79
Early exposure of interferon-γ inhibits signal transducer and activator of transcription-6 signalling and nuclear factor κB activation in a short-term monocyte-derived dendritic cell culture promoting 'FAST' regulatory dendritic cells. Clin Exp Immunol (2012) 0.79
Immune suppression in cynomolgus monkeys by XPro9523: an improved CTLA4-Ig fusion with enhanced binding to CD80, CD86 and neonatal Fc receptor FcRn. MAbs (2013) 0.79
Pancreas and islet cell transplantation. Best Pract Res Clin Gastroenterol (2002) 0.78
Induction of Pancreatic Islet Graft Acceptance: The Role of Antigen Presenting Cells. Transplant Sci (1992) 0.78
Manufacturing porcine islets: culture at 22 °C has no advantage above culture at 37 °C: a gene expression evaluation. Xenotransplantation (2013) 0.78
Allogeneic beta-islet cells correct diabetes and resist immune rejection. Proc Natl Acad Sci U S A (2002) 0.78
Induction of Ia antigen expression on murine islet parenchymal cells does not diminish islet allograft survival. Am J Pathol (1989) 0.77
Gordon Wilson lecture. The prevention of immune rejection of islet transplants without the use of immunosuppressive drugs. Trans Am Clin Climatol Assoc (1984) 0.77
Immunity and tolerance are related, and governed by antigen migration and localization. Transplant Proc (1999) 0.77
CTLA-4: not all costimulation is stimulatory. J Immunol (2011) 0.76
Cellular transplantation and gene therapy. Clin Transplant (1993) 0.75
Pancreatic islet transplantation--experimental experience and clinical potential. West J Med (1985) 0.75
Functional Characteristics of C-terminal Lysine to Cysteine Mutant Form of CTLA-4Ig. Immune Netw (2013) 0.75
The role of macrophages and bone marrow-derived dendritic cells in the rejection of fetal thymus allografts. Immunology (1994) 0.75
Regulation of immune reactivity and tolerance by antigen migration and localization: with particular reference to allo- and xenotransplantation. Transplant Proc (1999) 0.75
Effects of gliotoxin on Langerhans' cell function: contact hypersensitivity responses and skin graft survival. Immunology (1990) 0.75
Cell mediated immunity in human pathology: the importance of choosing the right weapon. Infect Dis Obstet Gynecol (1996) 0.75
Chimerism and xenotransplantation. New concepts. Surg Clin North Am (1999) 0.75
Treatment of an autoimmune disease with "classical" T cell veto: a proposal. J Clin Immunol (1999) 0.75
Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. Immunochemistry (1978) 22.56
A new analysis of allogeneic interactions. Aust J Exp Biol Med Sci (1975) 2.33
Effect of organ culture on the survival of thyroid allografts in mice. Transplantation (1976) 1.83
Activation of transplant immunity: effect of donor leukocytes on thyroid allograft rejection. Science (1976) 1.80
Thyroid allograft immunogenicity is reduced after a period in organ culture. Science (1975) 1.77
Role of lymphokine and antigen in the control of specific T cell responses. Immunol Rev (1980) 1.76
Cytokine response by monocytes and macrophages to free and lipoprotein-bound lipopolysaccharide. Infect Immun (1990) 1.74
Current status of immunological adjuvants. Annu Rev Immunol (1986) 1.65
Inhibition of T-cell activity by cyclosporin A. Scand J Immunol (1981) 1.61
The origin and mechanism of the allograft reaction. Immunol Rev (1977) 1.60
Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J Autoimmun (1993) 1.50
Reactions of the graft versus host (GVH) type. Aust J Exp Biol Med Sci (1969) 1.49
Malarial immunodepression in vitro: adherent spleen cells are functionally defective as accessory cells in the response to horse erythrocytes. Eur J Immunol (1976) 1.47
Molecular composition of the peri-islet basement membrane in NOD mice: a barrier against destructive insulitis. Diabetologia (2008) 1.41
Effect of adjuvant therapy on development of diabetes in mouse and man. Lancet (1994) 1.40
A novel granulocyte-derived peptide with lipopolysaccharide-neutralizing activity. J Immunol (1994) 1.39
An improved assay for interleukin 2 (lymphocyte growth factor) produced by mitogen-activated lymphocytes. Aust J Exp Biol Med Sci (1980) 1.38
Activation of cytotoxic T cells by nonstimulating tumor cells and spleen cell factor(s). Proc Natl Acad Sci U S A (1977) 1.38
Allogeneic stimulation modulates the in vitro response of T cells to transplantation antigen. Nature (1974) 1.37
Complement-fixing IgG1 constitutes a new subclass of mouse IgG. Nature (1979) 1.34
Strategies for the treatment of sepsis. N Engl J Med (1997) 1.33
The Th1/Th2 balance in autoimmunity. Curr Opin Immunol (1995) 1.32
Intestinal alkaline phosphatase preserves the normal homeostasis of gut microbiota. Gut (2010) 1.31
Turbidimetric method for quantifying serum inhibition of Limulus amoebocyte lysate. J Clin Microbiol (1985) 1.30
Neutralization of bacterial lipopolysaccharides by human plasma. J Clin Microbiol (1985) 1.25
The role of the lymphatic system and lymphoid cells in the establishment of immunological memory. Aust J Exp Biol Med Sci (1970) 1.24
Immunological induction of T lymphocytes: role of antigen and the lymphocyte costimulator. Blood Cells (1978) 1.23
Different colony-stimulating factors are detected by the "interleukin-3"-dependent cell lines FDC-Pl and 32D cl-23. Blood (1984) 1.21
The enchancement of virus infectivity by antibody. Virology (1967) 1.19
Autoimmune diabetes in NOD mouse is L3T4 T-lymphocyte dependent. Diabetes (1987) 1.17
Neutralization and lipoprotein binding of lipopolysaccharides in tolerant rabbit serum. J Infect Dis (1986) 1.17
Reversal of diabetes by allogenic islet transplantation without immunosuppression. Aust J Exp Biol Med Sci (1980) 1.15
Reversal diabetes by islet transplantation: vulnerability of the established allograft. Science (1981) 1.10
A novel peptide-IgG conjugate, CAP18(106-138)-IgG, that binds and neutralizes endotoxin and kills gram-negative bacteria. J Infect Dis (1997) 1.10
Cellular distribution of endotoxin after injection of chemically purified lipopolysaccharide differs from that after injection of live bacteria. J Infect Dis (1994) 1.09
Interleukin 2 production by both Ly2+ and Ly2- T-cell subsets. Scand J Immunol (1981) 1.09
Evidence of recurrent autoimmunity in human allogeneic islet transplantation. Transplantation (1996) 1.08
Immunoglobulin-deficient rats fail to develop experimental allergic encephalomyelitis. J Neuroimmunol (1983) 1.07
The role of CD4+ and CD8+ T cells in the destruction of islet grafts by spontaneously diabetic mice. Proc Natl Acad Sci U S A (1991) 1.05
Interleukin 2 production by alloantigen (H-2) activated T cells. Aust J Exp Biol Med Sci (1981) 1.04
Successful allotransplantation of mouse pancreatic islets to nonimmunosuppressed recipients. Diabetes (1980) 1.04
Relationship of tissue and cellular interleukin-1 and lipopolysaccharide after endotoxemia and bacteremia. J Infect Dis (1997) 1.04
Circulating lymphocyte populations and autoantibodies in non-obese diabetic (NOD) mice: a longitudinal study. Clin Exp Immunol (1987) 1.04
Islet cytotoxicity of interleukin 1. Influence of culture conditions and islet donor characteristics. Diabetes (1987) 1.04
Active immunization with a detoxified Escherichia coli J5 lipopolysaccharide group B meningococcal outer membrane protein complex vaccine protects animals from experimental sepsis. J Infect Dis (2001) 1.04
A polyanion binding site on the CD4 molecule. Proximity to the HIV-gp120 binding region. J Immunol (1990) 1.01
Combined treatment with nicotinamide and desferrioxamine prevents islet allograft destruction in NOD mice. Diabetes (1986) 1.01
CD8 T cells are not required for islet destruction induced by a CD4+ islet-specific T-cell clone. Diabetes (1992) 1.01
Cross-reactivity of rabbit antibodies to lipopolysaccharides of Escherichia coli J5 and other gram-negative bacteria. J Infect Dis (1985) 1.00
Diabetes results from a late change in the autoimmune response of NOD mice. J Autoimmun (1997) 1.00
Release of gram-negative outer-membrane proteins into human serum and septic rat blood and their interactions with immunoglobulin in antiserum to Escherichia coli J5. J Infect Dis (2000) 0.99
RS-61443 allows islet allografting and specific tolerance induction in adult mice. Transplant Proc (1990) 0.99
A simple conservative explanation of the H-2 restriction of interactions between lymphocytes. Scand J Immunol (1977) 0.98
The development of resistance in different inbred strains of mice to infection with Nematospiroides dubius. Parasite Immunol (1979) 0.98
Outer membrane protein A, peptidoglycan-associated lipoprotein, and murein lipoprotein are released by Escherichia coli bacteria into serum. Infect Immun (2000) 0.98
Human bone marrow allograft recipients: production of, and responsiveness to, interleukin 2. J Immunol (1983) 0.97
Cultured thyroid allografts induce a state of partial tolerance in adult recipient mice. Transplantation (1983) 0.96
CD48 is a low affinity ligand for human CD2. J Immunol (1993) 0.94
Autoimmune diabetes: the involvement of benign and malignant autoimmunity. J Autoimmun (1999) 0.94
Preparation and characterization of human bone marrow-derived macrophages. J Leukoc Biol (1985) 0.94
Studies on chronic versus transient intestinal nematode infections in mice. I. A. comparison of responses to excretory/secretory (ES) products of Nippostrongylus brasiliensis and Nematospiroides dubius worms. Parasite Immunol (1979) 0.94
Role of interleukin-1 in augmenting serum neutralization of bacterial lipopolysaccharide. J Clin Microbiol (1987) 0.93
Binding and neutralization of bacterial lipopolysaccharide by colistin nonapeptide. Antimicrob Agents Chemother (1985) 0.93
Differentiation of NK-like cells from OKT3-, OKT11+, and OKM1+ small resting lymphocytes by culture with autologous T cell blasts and lymphokine. J Immunol (1984) 0.93
The pathogenesis of the graft-versus-host reaction in chicken embryos. Pathological changes in the yolk sac, thymus, bone marrow and bursa of Fabricius. Aust J Exp Biol Med Sci (1972) 0.93
A long-term study in Merino sheep experimentally infected with Mycobacterium avium subsp. paratuberculosis: clinical disease, faecal culture and immunological studies. Vet Microbiol (2004) 0.92
Desferrioxamine treatment prevents chronic islet allograft damage. Diabetes (1986) 0.92
In vivo effects of chicken interferon-gamma during infection with Eimeria. J Interferon Cytokine Res (1997) 0.92
Heterogeneity in the activation requirements of T cells stimulated by phytohaemagglutinin. Immunology (1987) 0.92
Generation of homogeneous populations of alloreactive T cells in vitro. Aust J Exp Biol Med Sci (1979) 0.91
Antiserum against Escherichia coli J5 contains antibodies reactive with outer membrane proteins of heterologous gram-negative bacteria. J Infect Dis (1997) 0.91
Immunogenicity of foreign tissues. Transplantation (1980) 0.90
Localization of endotoxin in the rat intestinal epithelium. J Infect Dis (2000) 0.90
Mycophenolate mofetil can prevent the development of diabetes in BB rats. Ann N Y Acad Sci (1993) 0.90
A long-term study in Angora goats experimentally infected with Mycobacterium avium subsp. paratuberculosis: clinical disease, faecal culture and immunological studies. Vet Microbiol (2005) 0.90
Theory of allogeneic reactivity and its relevance to transplantation biology. Transplant Proc (1976) 0.90
Involvement of O2 radicals in 'autoimmune' diabetes. Immunol Cell Biol (1989) 0.89
Facilitation of specific tolerance induction in adult mice by RS-61443. Transplantation (1992) 0.89
Unexpected new roles for heparanase in Type 1 diabetes and immune gene regulation. Matrix Biol (2013) 0.89
A model of infected burn wounds using Escherichia coli O18:K1:H7 for the study of gram-negative bacteremia and sepsis. Infect Immun (2000) 0.88
Binding of a dimeric derivative of vancomycin to L-Lys-D-Ala-D-lactate in solution and at a surface. Chem Biol (1999) 0.88
Mechanism of thyroid allograft rejection. Aust J Exp Biol Med Sci (1976) 0.87
A method for the production and quantitative assay of human lymphokine preparations. J Immunol Methods (1981) 0.87
Characterization of primary T cell subsets mediating rejection of pancreatic islet grafts. J Immunol (1989) 0.87
Lysosomal enzyme release in canine endotoxin shock treated with methylprednisolone. Am Surg (1973) 0.86
The role of CD4 and CD8 T cells in the development of autoimmune diabetes. J Autoimmun (1999) 0.86
Pancreatic islet allograft immunity and tolerance: the two-signal hypothesis revisited. Immunol Rev (1996) 0.86
Lymphokine production by peripheral blood leucocytes: quantitation of T-cell growth factor activity for assessment of immune response capability. Aust N Z J Med (1981) 0.86
Nematospiroides dubius: susceptibility to infection and the development of resistance in hypothymic (nude) BALB/c mice. Aust J Exp Biol Med Sci (1978) 0.85
Cellular changes in cultured mouse thyroid glands and islets of Langerhans. Transplantation (1980) 0.85
Pathogenesis of the graft-versus-host reaction in chicken embryos. The development of haemorrhagic lesions. Aust J Exp Biol Med Sci (1973) 0.85